- Home
- LZ vs MDXG Comparison
LZ vs MDXG Comparison
Compare LZ & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZ
- MDXG
- Stock Information
- Founded
- LZ 2001
- MDXG 2006
- Country
- LZ United States
- MDXG United States
- Employees
- LZ N/A
- MDXG N/A
- Industry
- LZ EDP Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- LZ Technology
- MDXG Health Care
- Exchange
- LZ Nasdaq
- MDXG Nasdaq
- Market Cap
- LZ 1.4B
- MDXG 1.1B
- IPO Year
- LZ 2021
- MDXG N/A
- Fundamental
- Price
- LZ $7.77
- MDXG $9.22
- Analyst Decision
- LZ Hold
- MDXG Strong Buy
- Analyst Count
- LZ 8
- MDXG 5
- Target Price
- LZ $7.90
- MDXG $12.00
- AVG Volume (30 Days)
- LZ 1.3M
- MDXG 1.1M
- Earning Date
- LZ 11-06-2024
- MDXG 10-30-2024
- Dividend Yield
- LZ N/A
- MDXG N/A
- EPS Growth
- LZ 212.91
- MDXG N/A
- EPS
- LZ 0.13
- MDXG 0.52
- Revenue
- LZ $678,838,000.00
- MDXG $342,804,000.00
- Revenue This Year
- LZ $6.04
- MDXG $9.56
- Revenue Next Year
- LZ $2.80
- MDXG $9.19
- P/E Ratio
- LZ $58.44
- MDXG $17.84
- Revenue Growth
- LZ 4.65
- MDXG 10.93
- 52 Week Low
- LZ $5.33
- MDXG $5.47
- 52 Week High
- LZ $13.74
- MDXG $9.49
- Technical
- Relative Strength Index (RSI)
- LZ 51.87
- MDXG 79.76
- Support Level
- LZ $7.44
- MDXG $8.55
- Resistance Level
- LZ $8.00
- MDXG $9.49
- Average True Range (ATR)
- LZ 0.32
- MDXG 0.42
- MACD
- LZ -0.09
- MDXG 0.17
- Stochastic Oscillator
- LZ 26.25
- MDXG 89.66
About LZ LegalZoom.com Inc.
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.